Bergamot Extract for Metabolic & Lipid Support — Aging
Citrus bergamia extract rich in polyphenols (brutieridin, melitidin) with emerging evidence for cholesterol reduction and metabolic syndrome support.
Overview
Bergamot (Citrus bergamia Risso & Poiteau) is a citrus fruit native to Calabria, Italy, whose juice and peel extract contain uniquely high concentrations of polyphenolic flavonoids including brutieridin, melitidin, neoeriocitrin, naringin, and neohesperidin. Brutieridin and melitidin are structurally similar to the statin pharmacophore and act as competitive inhibitors of HMG-CoA reductase, providing a natural mechanism for cholesterol reduction. Clinical trials, primarily from Italian research groups, have demonstrated that standardized bergamot polyphenol fractions (BPF, 500-1500 mg/day) reduce total cholesterol by 15-25%, LDL-C by 20-35%, and triglycerides by 20-30% while increasing HDL-C by 15-25% in patients with hyperlipidemia. Additional metabolic benefits include improved fasting glucose, reduced hepatic steatosis markers, and enhanced endothelial function. A randomized, double-blind, placebo-controlled trial in metabolic syndrome patients showed significant improvements in multiple cardiometabolic parameters. However, limitations include relatively small sample sizes (typically 50-200 subjects), predominance of Italian research groups (potential geographic bias), and limited independent replication. Bergamot extract is generally well tolerated and is positioned as an alternative or adjunct for patients who are statin-intolerant or prefer natural lipid management approaches.
Indications
- Emerging evidence: LDL cholesterol and total cholesterol reduction
- Emerging evidence: Triglyceride lowering and HDL elevation
- Emerging evidence: Metabolic syndrome parameter improvement
- Emerging evidence: Non-alcoholic fatty liver disease (hepatic steatosis markers)
- Emerging evidence: Adjunct for statin-intolerant patients seeking lipid management
Mechanism of Action
Brutieridin and melitidin competitively inhibit HMG-CoA reductase — the same enzyme target as statins — reducing hepatic cholesterol synthesis
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Bergamot Polyphenol Fraction (BPF) | 500 mg | Once daily | Standard dose for mild lipid support |
| Bergamot Polyphenol Fraction (BPF) | 1000 mg | Once daily or divided | Most commonly studied clinical dose |
| Bergamot Polyphenol Fraction (BPF) | 1500 mg | Divided twice daily | Higher dose for metabolic syndrome; maximum studied |
Safety & Contraindications
- Generally well tolerated in clinical studies at 500-1500 mg/day
- Bergamot juice is phototoxic due to bergapten (furanocoumarins) — supplements are bergapten-free
- Theoretical CYP3A4 interaction (as with grapefruit) — use caution with CYP3A4-metabolized drugs
- GI discomfort and heartburn reported occasionally
- Do not use as sole therapy for clinically significant dyslipidemia requiring statin therapy
- Quality varies between products — choose standardized BPF supplements